In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials

Journal of Biomedical Materials Research - Part A

Volumn 82, Issue 3, 2007, Pages 740-746

  Pan, C J ^a,b   Shao, Z Y ^a   Tang, J J ^a   Wang, J ^a   Huang, N ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b CHONGQING UNIVERSITY   (China)

Author keywords

Blood compatibility; Curcumin; Drug eluting stent; Fibrinogen; Platelet

Indexed keywords

CELL ADHESION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PLATELETS; POLYMER FILMS; PROTEINS; X RAY PHOTOELECTRON SPECTROSCOPY;

BLOOD COMPATIBILITY; CURCUMIN; DRUG-ELUTING STENT; FIBRINOGEN; THROMBOSIS;

BIOMATERIALS;

CURCUMIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; POLYGLACTIN; PROTEIN;

ADSORPTION; ARTICLE; BIODEGRADABILITY; BLOOD COMPATIBILITY; CONTACT ANGLE; CORONARY STENT; DRUG ELUTING STENT; FIBRINOGEN METABOLISM; FILM; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PROTEIN ADSORPTION; RESTENOSIS; STRUCTURE ANALYSIS; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS PREVENTION; X RAY PHOTOELECTRON SPECTROSCOPY;

ADSORPTION; BIOCOMPATIBLE MATERIALS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CURCUMIN; LACTIC ACID; MATERIALS TESTING; PLATELET ACTIVATION; PLATELET ADHESIVENESS; POLYGLYCOLIC ACID; POLYMERS; PROTEINS; STENTS;

EID: 34547889980     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31108     Document Type: Article

References (25)

1. Nakayama Y, Nishi S, Ishibashi-Ueda H. Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506. Cardiovasc Radiat Med 2003;4:77-82.
2. Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, Schühlen H, Seyfarth M, Schmitt C, Blasini R, Neumann F-J, Schomig A. Restenosis after coronary placement of various stent types. Am J Cardiol 2001;87:34-39.
3. Peuster M, Fink C, Reckers J, Beerbaum P, von Schnakenburg C. Assessment of subacute inflammatory and proliferative response to coronary stenting in a porcine model by local gene expression studies and histomorphometry. Biomaterials 2004;25:957-963.
4. Stabile E, Cheneau E, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R. Late thrombosis in Cypher stents after discontinuation of anti-platelet therapy. Cardiovasc Radiat Med 2004;5:173-176.
5. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998;4:376-383.
6. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 1998;124:1029-1040.
7. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation. Biochem Pharmacol 1998;55:775-783.
8. Edelman ER, Nathan A, Katada M, Gates J, Karnovsky MJ. Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials 2000;21:2279-2286.
9. Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J Microencapsul 1990;7:297-325.
10. Brannon-Peppas L. Recent advances in the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995;116:1-9.
11. Groth T, Campbell EJ, Herrmann K, Seifert B. Application of enzyme immunoassays for testing haemocompatibility of biomedical polymers. Biomaterials 1995;16:1009-1015.
12. Nimeri G, Lassen B, Gölander CG, Nilsson U, Elwing H. Adsorption of fibrinogen and some other proteins from blood plasma at a variety of solid surfaces. J Biomater Sci Polym Ed 1991;2:173-181.
13. Gentry PA. The mammalian blood platelet: Its role in haemostasis, inflammation and tissue repair. J Comp Pathol 1992;107:243-270.
14. Mcever RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984;259:9799-9804.
15. Zhou J, Yuan J, Zang X, Shen J, Lin S. Platelet adhesion and protein adsorption on silicone rubber surface by ozone-induced grafted polymerization with carboxybetaine monomer. Colloids Surf B Biointerfaces 2005;41:55-62.
16. Srivastava R, Puri V, Srimal RC, Dhawan BN. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneimittelforschung 1986;36:715-717.
17. 2+ signaling. Biochem Pharmacol 1999;58:1167-1172.
18. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of anti inflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993;38(2/3):113-119.
19. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 1986;22:357-360.
20. Zhang F, Kang ET, Neoh KG, Wang P, Tan KL. Surface modification of stainless steel by grafting of poly(ethylene glycol) for reduction in protein adsorption. Biomaterials 2001;22:1541-1548.
21. Ishihara K, Fukumoto K, Iwasaki Y, Nakabayashi N. Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility, Part 2: Protein adsorption and platelet adhesion. Biomaterials 1999;20:1553-1559.
22. Lee JH, Ju YM, Kim DM. Platelet adhesion onto segmented polyurethane film surfaces modified by addition and cross-linking of PEO-containing block copolymers. Biomaterials 2000;21:683-691.
23. Eriksson AC, Whiss PA. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. J Pharmacol Toxicol Methods 2005;52:356-365.
24. Murugappan S, Shankar H, Kunapuli SP. Platelet receptors for adenine nucleotides and thromboxane A2. Semin Thromb Hemost 2004;30:411-418.
25. Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginineglycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me) (SC-46749). J Pharmacol Exp Ther 1991;256:876-882.